Perrigo up on FDA's nod for over-the-counter contraceptive pill

Perrigo

13/07/2023 13:57

** Shares of drugmaker Perrigo Co  PRGO.N  up 8.5% at $35.88
in premarket trading
    ** The U.S. Food and Drug Administration approved the
over-the-counter use of co's contraceptive pill, making it the
fist non-prescription birth control pill in the United States
    ** Co says, Opill will be available in store and online at
retailers across U.S. early in Q1 of 2024 
    ** Co said it plans to share additional information on
pricing and distribution next week
    ** As of last close, PRGO stock was down about 3% this year

 (Reporting by Pratik Jain in Bengaluru)
 ((Pratik.Jain@thomsonreuters.com;))